Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Valera Homes Launches in Greater Houston with Four Communities and a New Approach to Modern Homeownership

September 28, 2026

A Cup of Tea, A Meeting of Minds: TAETEA at the 2026 Reviving Craft Exhibition in London

September 28, 2026

Saviynt Appoints Michibumi Serizawa to Lead Japan’s AI-Era Identity Security Growth

September 28, 2026

Kelowna businesses raise safety concerns as mayoral candidates debate public safety

September 28, 2026

Glancy Prongay Wolke & Rotter LLP Obtains Final Approval of $15 Million Settlement in Evolv Technologies Securities Class Action

September 28, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma
Press Release

Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma

By News RoomSeptember 28, 20263 Mins Read
Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma
Share
Facebook Twitter LinkedIn Pinterest Email

SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) — Evosep™, a global leader in standardized proteomics workflows, today announced a strategic collaboration with Mass Dynamics™, the collaborative software environment for modern proteomics teams. Together, the companies will standardize the LC-MS proteomics workflow end-to-end – from sample preparation and measurement through to quality control, interpretation and reproducibility across pharmaceutical teams, studies and sites.

Morten Bern, CEO of Evosep, commented:

“Sample preparation remains one of the largest sources of variability in proteomics. Through this collaboration, we can provide customers with a standardized solution that combines automated sample preparation with software-driven quality control, enabling reproducible proteomics at pharmaceutical scale.”

Addressing a Critical Need in Pharma

As LC-MS proteomics becomes increasingly important for biomarker discovery, target validation, translational research, and drug development, pharmaceutical organizations require workflows that can deliver consistent results as studies increase in size, complexity, and volume.

By combining Evosep’s standardized sample preparation platform with Mass Dynamics’ collaborative software environment, pharmaceutical teams gain:

  • Standardized and automated sample preparation
  • Built-in quality control and system suitability monitoring
  • Confidence in reproducible results across large cohorts, laboratories, and sites
  • Consistent analytical interpretation across studies and scientists
  • Faster delivery of reliable proteomics insights for drug discovery and development.

Paula Burton CEO Mass Dynamics

Paula Burton, CEO, Mass Dynamics, commented:

“Standardizing the experiment is what makes everything downstream possible. Pharmaceutical organizations also need biological interpretation to be reproducible, connected, traceable, and reusable. By connecting standardized sample preparation with a shared analytical environment, each experiment can build on the work that came before it – allowing proteomics knowledge to compound across teams, studies, and increasingly automated scientific workflows.”

Delivering Sample to Separation Standardization, and Beyond to Reusable Biological Knowledge

Evosep Proteomics™, introduced at ASMS 2026, was developed to standardize proteomics workflows across laboratories. At the core of the collaboration are Evosep Lupo™, Evokits, and Evotip™ technology, which together provide automated and reproducible sample preparation.

Mass Dynamics extends this standardization into the analytical and biological layer, giving proteomics teams one environment in which to quality-control experiments, run reproducible analyses and compare results across studies.

The collaboration combines:

  • Evosep Lupo, plug and play sample preparation system designed exclusively for Evokits
  • Evokits, standardized sample preparation kits with automated protocols
    • MD QC, Mass Dynamics’ quality control and system suitability monitoring, available with every Evosep Lupo and Evokit™ purchase.

Together, these technologies create a reproducible path from biological sample to biological knowledge – helping pharmaceutical and biotechnology organizations scale proteomics while preserving consistency, transparency, and trust.

For more information, please call +45 2633 2021, e-mail [email protected], or visit evosep.com

About Evosep

Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics, initially through collaborations with world-leading scientists about developing new technologies and solutions to make sample separation 100 times more robust and 10 times faster than today’s alternatives. Information about Evosep is available at evosep.com.

The Evosep Eno™ is classified as General Laboratory Equipment. Evosep and Evotip are registered trademarks of Evosep in the US.

About Mass Dynamics

Mass Dynamics is the agent-ready software environment for proteomics and multi-omics that helps scientists turn quantitative omics data into structured, reproducible biological knowledge, without rebuilding their infrastructure as the science evolves.

Built so both scientists and their agents work over the same connected, reproducible data, Mass Dynamics helps discoveries compound over time. Connected. Reproducible. Dynamic.

Information about Mass Dynamics is available at massdynamics.com.

Figure one - Evosep_proteomics_2026

Figure One: Evokit, Evosep Lupo, Evotip, Evosep Eno forms Evosep Proteomics – a unified sample-to-separation platform built for reproducibility, scalability, and AI-ready proteomic insights.

Media Contact Information:
Christian Ravnsborg
+ 45 26 33 20 21
[email protected]

Photos accompanying this announcement are available at 
https://www.globenewswire.com/NewsRoom/AttachmentNg/4c94a437-5b91-43e5-8a43-24b33dfb7872
https://www.globenewswire.com/NewsRoom/AttachmentNg/6210370b-5578-4822-925a-04fd251d0b59
https://www.globenewswire.com/NewsRoom/AttachmentNg/e97eb3d7-838a-4d42-be69-8395ae06ff67

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Valera Homes Launches in Greater Houston with Four Communities and a New Approach to Modern Homeownership

A Cup of Tea, A Meeting of Minds: TAETEA at the 2026 Reviving Craft Exhibition in London

Saviynt Appoints Michibumi Serizawa to Lead Japan’s AI-Era Identity Security Growth

Glancy Prongay Wolke & Rotter LLP Obtains Final Approval of $15 Million Settlement in Evolv Technologies Securities Class Action

New Crypto: AlphaPepe Presale To Announce 5th CEX Within 2 Weeks While Solana Price Prediction Targets $1,000

IKO launches IKO Metals, bringing DECRA stone-coated steel roofing into its North American portfolio

Soulog Launches Soulog Sense, an AI voice recorder with Personal Context System That Turns Conversations Into Deliverables

2-Seater, 3-Seater, L-Shaped and Sofa Cum Bed Rentals Rise in Delhi in 2026 as ₹25,000–₹65,000 Purchase Costs Push Tenants Toward ₹249/Month Plans From Rentomojo

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

Editors Picks

A Cup of Tea, A Meeting of Minds: TAETEA at the 2026 Reviving Craft Exhibition in London

September 28, 2026

Saviynt Appoints Michibumi Serizawa to Lead Japan’s AI-Era Identity Security Growth

September 28, 2026

Kelowna businesses raise safety concerns as mayoral candidates debate public safety

September 28, 2026

Glancy Prongay Wolke & Rotter LLP Obtains Final Approval of $15 Million Settlement in Evolv Technologies Securities Class Action

September 28, 2026

Latest News

Nothing’s new flagship Headphone 1 Pro put you in the studio

September 28, 2026

New Crypto: AlphaPepe Presale To Announce 5th CEX Within 2 Weeks While Solana Price Prediction Targets $1,000

September 28, 2026

Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma

September 28, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version